These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22956440)

  • 1. Effectiveness of vaccines and vaccination programs for the control of foot-and-mouth disease in Uganda, 2001-2010.
    Muleme M; Barigye R; Khaitsa ML; Berry E; Wamono AW; Ayebazibwe C
    Trop Anim Health Prod; 2013 Jan; 45(1):35-43. PubMed ID: 22956440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey.
    Knight-Jones TJ; Bulut AN; Gubbins S; Stärk KD; Pfeiffer DU; Sumption KJ; Paton DJ
    Vaccine; 2014 Apr; 32(16):1848-55. PubMed ID: 24530150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
    Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of foot and mouth disease (FMD) vaccine using registered surveillance data.
    Emami SJ; Bahonar AR; Mehrabadi MHF; Lotfollazadeh S; Amiri K; Abdollahi D
    Trop Anim Health Prod; 2022 Jun; 54(4):215. PubMed ID: 35723776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled field trial assessing foot and mouth disease vaccine effectiveness in Gondar Zuria district, Northwest Ethiopia.
    Jemberu WT; Molla W; Fentie T
    Prev Vet Med; 2020 Oct; 183():105136. PubMed ID: 32977170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease.
    Elnekave E; Li Y; Zamir L; Even-Tov B; Hamblin P; Gelman B; Hammond J; Klement E
    Vaccine; 2013 Jan; 31(6):879-85. PubMed ID: 23246551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of foot and mouth disease hotspots in northern Lao PDR.
    Nampanya S; Richards J; Khounsy S; Inthavong P; Yang M; Rast L; Windsor PA
    Transbound Emerg Dis; 2013 Aug; 60(4):315-29. PubMed ID: 22690839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies II: Waiting Periods After Emergency Vaccination in FMD Free Countries.
    Geale DW; Barnett PV; Clarke GW; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):388-406. PubMed ID: 24131661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges for Serology-Based Characterization of Foot-and-Mouth Disease Outbreaks in Endemic Areas; Identification of Two Separate Lineages of Serotype O FMDV in Uganda in 2011.
    Namatovu A; Belsham GJ; Ayebazibwe C; Dhikusooka MT; Wekesa SN; Siegismund HR; Muwanika VB; Tjørnehøj K
    Transbound Emerg Dis; 2015 Oct; 62(5):522-34. PubMed ID: 24118785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vaccination on cattle subclinically infected with foot-and-mouth disease virus in Cameroon.
    Bertram MR; Delgado A; Pauszek SJ; Smoliga GR; Brito B; Stenfeldt C; Hartwig EJ; Jumbo SD; Abdoulmoumini M; Oliva Marie AA; Salhine R; Rodriguez LL; Garabed R; Arzt J
    Prev Vet Med; 2018 Jul; 155():1-10. PubMed ID: 29786519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG
    Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance.
    Barnett PV; Geale DW; Clarke G; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):367-87. PubMed ID: 24112127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
    Steigerwald R; Brake DA; Barrera J; Schutta CJ; Kalla M; Wennier ST; Volkmann A; Hurtle W; Clark BA; Zurita M; Pisano M; Kamicker BJ; Puckette MC; Rasmussen MV; Neilan JG
    Vaccine; 2020 Jan; 38(4):769-778. PubMed ID: 31718901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for foot and mouth disease outbreaks in grazing beef cattle herds.
    Elnekave E; Zamir L; Hamd F; Even Tov B; Klement E
    Prev Vet Med; 2015 Jun; 120(2):236-240. PubMed ID: 25841998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and control measures of the 2010 outbreak of foot-and-mouth disease A type in the Republic of Korea.
    Park JH; Lee KN; Ko YJ; Kim SM; Lee HS; Park JY; Yeh JY; Kim MJ; Lee YH; Sohn HJ; Cho IS; Kim B
    Transbound Emerg Dis; 2013 Apr; 60(2):188-92. PubMed ID: 22630568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foot-and-mouth disease virus transmission dynamics and persistence in a herd of vaccinated dairy cattle in India.
    Hayer SS; VanderWaal K; Ranjan R; Biswal JK; Subramaniam S; Mohapatra JK; Sharma GK; Rout M; Dash BB; Das B; Prusty BR; Sharma AK; Stenfeldt C; Perez A; Delgado AH; Sharma MK; Rodriguez LL; Pattnaik B; Arzt J
    Transbound Emerg Dis; 2018 Apr; 65(2):e404-e415. PubMed ID: 29205858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in the Antibody Response to Foot-and-Mouth Disease Primo-vaccinated Calves.
    Di Giacomo S; Brito BP; Perez AM; Bucafusco D; Pega J; Rodríguez L; Borca MV; Pérez-Filgueira M
    Transbound Emerg Dis; 2015 Jun; 62(3):280-7. PubMed ID: 23895140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological analysis of an outbreak of foot-and-mouth disease (serotype SAT2) on a large dairy farm in Kenya using regular vaccination.
    Lyons NA; Stärk KD; van Maanen C; Thomas SL; Chepkwony EC; Sangula AK; Dulu TD; Fine PE
    Acta Trop; 2015 Mar; 143():103-11. PubMed ID: 25447264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of financial impact of foot and mouth disease on smallholder cattle farmers in Southern Cambodia.
    Young JR; Suon S; Andrews CJ; Henry LA; Windsor PA
    Transbound Emerg Dis; 2013 Apr; 60(2):166-74. PubMed ID: 22510453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.